Is increased HCV case-finding combined with current or 8-12 week DAA therapy cost-effective in UK prisons? A prevention benefit analysis.

Martin, NK; Vickerman, P; Brew, IF; Williamson, J; Miners, A; Irving, WL; Saksena, S; Hutchinson, SJ; Mandal, S; O'Moore, E; +1 more... Hickman, M; (2016) Is increased HCV case-finding combined with current or 8-12 week DAA therapy cost-effective in UK prisons? A prevention benefit analysis. Hepatology (Baltimore, Md), 63 (6). pp. 1796-808. ISSN 0270-9139 DOI: https://doi.org/10.1002/hep.28497

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1002/hep.28497

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar